CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Patel Sanj K Chairman & CEO | Option exercise | +4,924 | $1.59 | $8K | 4,924 |
| 2021-02-08 | Patel Sanj K Chairman & CEO | Sale | −4,924 | $23.00 | $113K | 0 |
| 2021-02-08 | Patel Sanj K Chairman & CEO | Sale | −4,528 | $23.00 | $104K | 108,042 |
| 2021-02-08 | Patel Sanj K Chairman & CEO | Option exercise · Share Option | −4,924 | 347,272 | ||
| 2021-02-03 | Beetham Thomas W. EVP & Chief Legal Officer | Conversion | +300,000 | 300,000 | ||
| 2021-02-03 | Beetham Thomas W. EVP & Chief Legal Officer | Sale | −2,477 | $22.09 | $55K | 297,523 |
| 2021-02-03 | Beetham Thomas W. EVP & Chief Legal Officer | Conversion · Class B Common Shares | −300,000 | 114,157 | ||
| 2020-12-31 | Megna Michael R Chief Accounting Officer | Grant or award | +405 | $15.02 | $6K | 2,183 |
| 2020-12-31 | Ragosa Mark Interim CFO | Option exercise | +4,404 | 4,404 | ||
| 2020-12-31 | Ragosa Mark Interim CFO | Shares withheld for taxes | −1,297 | $17.67 | $23K | 3,107 |
| 2020-12-31 | Ragosa Mark Interim CFO | Option exercise · Restricted Share Unit | −4,404 | 0 | ||
| 2020-12-31 | Rizvi Qasim Chief Commercial Officer | Option exercise | +7,337 | 7,337 | ||
| 2020-12-31 | Rizvi Qasim Chief Commercial Officer | Shares withheld for taxes | −2,161 | $17.67 | $38K | 5,176 |
| 2020-12-31 | Rizvi Qasim Chief Commercial Officer | Option exercise · Restricted Share Unit | −7,337 | 0 | ||
| 2020-10-12 | Patel Sanj K Chairman & CEO | Option exercise | +150,700 | $1.59 | $240K | 150,700 |
| 2020-10-12 | Patel Sanj K Chairman & CEO | Sale | −150,700 | $21.02 | $3.2M | 0 |
| 2020-10-12 | Patel Sanj K Chairman & CEO | Sale | −99,330 | $21.02 | $2.1M | 112,570 |
| 2020-10-12 | Patel Sanj K Chairman & CEO | Option exercise · Share Option | −150,700 | 352,196 | ||
| 2020-10-09 | Patel Sanj K Chairman & CEO | Option exercise | +872 | $1.59 | $1K | 872 |
| 2020-10-09 | Patel Sanj K Chairman & CEO | Sale | −872 | $21.00 | $18K | 0 |
Page 73 of 74 · 1,467 trades